DE60136088D1 - Heteroarylacryloylaminoalkyl-substituierte benzolsulfonamidderivate, deren herstellung, deren verwendung und pharmazeutische zusammensetzungen, die diese verbindungen enthalten - Google Patents
Heteroarylacryloylaminoalkyl-substituierte benzolsulfonamidderivate, deren herstellung, deren verwendung und pharmazeutische zusammensetzungen, die diese verbindungen enthaltenInfo
- Publication number
- DE60136088D1 DE60136088D1 DE60136088T DE60136088T DE60136088D1 DE 60136088 D1 DE60136088 D1 DE 60136088D1 DE 60136088 T DE60136088 T DE 60136088T DE 60136088 T DE60136088 T DE 60136088T DE 60136088 D1 DE60136088 D1 DE 60136088D1
- Authority
- DE
- Germany
- Prior art keywords
- compounds
- heteroarylacryloylaminoalkyl
- preparation
- cardiac
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10054482A DE10054482A1 (de) | 2000-11-03 | 2000-11-03 | Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
PCT/EP2001/012142 WO2002036565A1 (en) | 2000-11-03 | 2001-10-20 | Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60136088D1 true DE60136088D1 (de) | 2008-11-20 |
Family
ID=7662010
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE10054482A Withdrawn DE10054482A1 (de) | 2000-11-03 | 2000-11-03 | Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE60136088T Expired - Lifetime DE60136088D1 (de) | 2000-11-03 | 2001-10-20 | Heteroarylacryloylaminoalkyl-substituierte benzolsulfonamidderivate, deren herstellung, deren verwendung und pharmazeutische zusammensetzungen, die diese verbindungen enthalten |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE10054482A Withdrawn DE10054482A1 (de) | 2000-11-03 | 2000-11-03 | Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
Country Status (13)
Country | Link |
---|---|
US (1) | US6472413B2 (de) |
EP (1) | EP1335902B1 (de) |
JP (1) | JP4281991B2 (de) |
AT (1) | ATE410414T1 (de) |
AU (2) | AU2363102A (de) |
CA (1) | CA2427548C (de) |
DE (2) | DE10054482A1 (de) |
DK (1) | DK1335902T3 (de) |
ES (1) | ES2315314T3 (de) |
IL (2) | IL155658A0 (de) |
MX (1) | MXPA03003778A (de) |
PT (1) | PT1335902E (de) |
WO (1) | WO2002036565A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6956846B2 (en) * | 2002-08-16 | 2005-10-18 | Utstarcom Incorporated | System and method for foreign agent control node redundancy in a mobile internet protocol network |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1185180B (de) | 1963-10-19 | 1965-01-14 | Hoechst Ag | Verfahren zur Herstellung von Benzolsulfonylharnstoffen |
DE1493672C3 (de) * | 1964-08-01 | 1974-05-02 | Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt | Verfahren zur Herstellung von Benzolsulfonylharnstoffen |
DE1518874C3 (de) | 1964-10-07 | 1975-03-13 | Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt | Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung |
DE1518816C3 (de) | 1965-03-24 | 1975-05-22 | Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt | Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate |
US4066639A (en) | 1965-05-06 | 1978-01-03 | Hoechst Aktiengesellschaft | Benzene-sulfonyl semicarbazides and process for preparing them |
DE59401361D1 (de) | 1993-02-23 | 1997-02-06 | Hoechst Ag | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika |
DE4341655A1 (de) | 1993-12-07 | 1995-06-08 | Hoechst Ag | Aminosubstituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika |
DE19505397A1 (de) | 1995-02-17 | 1996-08-22 | Hoechst Ag | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19832009A1 (de) * | 1998-07-16 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | 2,5-Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharamazeutische Präparate |
ES2235507T3 (es) | 1998-09-10 | 2005-07-01 | Aventis Pharma Deutschland Gmbh | Bencenosulfoni(tio)ureas en combinacion con bloqueadores beta para el tratamiento de disfunciones del sistema nervioso autonomo. |
DE19923086A1 (de) * | 1999-05-20 | 2000-11-23 | Aventis Pharma Gmbh | Cinnamoylaminoalkyl-substituierte Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
-
2000
- 2000-11-03 DE DE10054482A patent/DE10054482A1/de not_active Withdrawn
-
2001
- 2001-10-20 AU AU2363102A patent/AU2363102A/xx active Pending
- 2001-10-20 IL IL15565801A patent/IL155658A0/xx unknown
- 2001-10-20 DK DK01992700T patent/DK1335902T3/da active
- 2001-10-20 JP JP2002539325A patent/JP4281991B2/ja not_active Expired - Fee Related
- 2001-10-20 MX MXPA03003778A patent/MXPA03003778A/es active IP Right Grant
- 2001-10-20 DE DE60136088T patent/DE60136088D1/de not_active Expired - Lifetime
- 2001-10-20 WO PCT/EP2001/012142 patent/WO2002036565A1/en active Application Filing
- 2001-10-20 PT PT01992700T patent/PT1335902E/pt unknown
- 2001-10-20 EP EP01992700A patent/EP1335902B1/de not_active Expired - Lifetime
- 2001-10-20 AT AT01992700T patent/ATE410414T1/de active
- 2001-10-20 ES ES01992700T patent/ES2315314T3/es not_active Expired - Lifetime
- 2001-10-20 CA CA2427548A patent/CA2427548C/en not_active Expired - Fee Related
- 2001-10-20 AU AU2002223631A patent/AU2002223631B2/en not_active Ceased
- 2001-11-02 US US09/985,359 patent/US6472413B2/en not_active Expired - Lifetime
-
2003
- 2003-04-29 IL IL155658A patent/IL155658A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP4281991B2 (ja) | 2009-06-17 |
EP1335902B1 (de) | 2008-10-08 |
WO2002036565A1 (en) | 2002-05-10 |
US20020123495A1 (en) | 2002-09-05 |
AU2363102A (en) | 2002-05-15 |
DK1335902T3 (da) | 2009-02-16 |
IL155658A0 (en) | 2003-11-23 |
CA2427548A1 (en) | 2002-05-10 |
MXPA03003778A (es) | 2003-07-28 |
ES2315314T3 (es) | 2009-04-01 |
PT1335902E (pt) | 2009-01-19 |
US6472413B2 (en) | 2002-10-29 |
IL155658A (en) | 2010-04-15 |
CA2427548C (en) | 2010-11-16 |
AU2002223631B2 (en) | 2006-07-06 |
DE10054482A1 (de) | 2002-05-08 |
EP1335902A1 (de) | 2003-08-20 |
JP2004513114A (ja) | 2004-04-30 |
ATE410414T1 (de) | 2008-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60109324D1 (de) | Acylaminoalkyl-substituierte benzolsulfonamidderivate | |
WO2003048164A3 (en) | Adenosine a2a receptor antagonists | |
CA2468649A1 (en) | Adenosine a2a receptor antagonists | |
EP0444196A4 (en) | Agent for treatment and prophylaxis of ischemic disease of heart or brain | |
WO1998032442A1 (de) | Chinoxaline in dreier-kombination mit proteaseinhibitoren und reverse transkriptaseinhibitoren als arzneimittel zur behandlung von aids | |
DE69837564T2 (de) | Azaheterozyklische derivate zur behandlung von haarausfall und neurologischer krankheiten | |
DE19506742A1 (de) | Verwendung von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen | |
DK1124841T3 (da) | Substituerede phenylalkenoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler eller diagnosemidler og lægemidler, som indeholder dem | |
DK0748314T3 (da) | Tetrasubstituerede imidazolderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf | |
DE60136088D1 (de) | Heteroarylacryloylaminoalkyl-substituierte benzolsulfonamidderivate, deren herstellung, deren verwendung und pharmazeutische zusammensetzungen, die diese verbindungen enthalten | |
MX2009012644A (es) | Derivados de di(hetero)arilciclohexano, su preparacion, su uso y composiciones farmaceuticas que los comprenden. | |
WO2000003978A3 (de) | 2,5-substituierte benzolsulfonylharnstoffe und -thioharnstoffe, v,rfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate | |
CA2534833A1 (en) | Bicyclo[3.1.1]heptane substituted benzimidazolone and quinazoli-none derivatives as agonists on human orl1 receptors | |
HK1113353A1 (en) | Piperidinesulfonylureas and-thioureas, their preparation, their use and pharmaceutical compositions comprising them | |
HRP20010845A9 (en) | Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives | |
IL159767A0 (en) | Sulfonamide derivatives, their preparation and pharmacetuical compositions containing them | |
NZ527216A (en) | Regulation of organic nitrate tolerance | |
DE68905278T2 (de) | Pharmazeutische zusammensetzungen. | |
ATE265459T1 (de) | Triazolpurin-derivate, medikamentzusammensetzungen, die diese enthalten und mittel, die affinität zum adenosin a3 rezeptor zeigen | |
JPS63146839A (ja) | プテロシン系化合物を含んで成る制癌剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |